Opus Genetics

Opus Genetics Assets per Share

The Total Assets per Share of Opus Genetics (IRD) as of Oct 17, 2026 is 0.73 USD. In the previous year, Total Assets per Share was 0.53 USD — a change of 36.30% (higher).

Assets per Share

0.73USD

YoY

36.30%

Last updated:

Total Assets per Share of Opus Genetics is 2025 0.73 USD. Total Assets per Share of Opus Genetics was 2024 0.53 USD. It decreases by 36.30% higher compared to the previous year.

The Opus Genetics Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2018
0.23 USD
Jan 1, 2019
0.03 USD
Jan 1, 2020
0.26 USD
Jan 1, 2021
0.38 USD
Jan 1, 2022
0.71 USD
Jan 1, 2023
0.78 USD
Jan 1, 2024
0.53 USD
Jan 1, 2025
0.73 USD
The Opus Genetics Assets per Share history
YEARAssets per ShareYoY
0.73USD+36.30%
0.53USD-31.67%
0.78USD+10.12%
0.71USD+87.87%
0.38USD+47.48%
0.26USD+891.14%
0.03USD-88.88%
0.23USD-43.30%
0.41USD+34.46%
0.31USD-15.20%
0.36USD-26.01%
0.49USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Opus Genetics Stock analysis

What does Opus Genetics do? Ocuphire Pharma, Inc. is a health care company based in Farmington Hills, Michigan, specializing in the research and development of ophthalmic biopharmaceuticals. Listed on the market on 30 November 2004, the firm focuses on therapies for refractive and retinal eye disorders. Its pipeline features Nyxol Eye Drops, a once-daily formulation of phentolamine mesylate aimed at reducing pupil diameter and improving visual acuity for conditions such as presbyopia and night vision disturbances. Additionally, the company develops APX3330, an oral tablet targeting retinal and choroidal diseases, alongside in-licensed second-generation candidates APX2009 and APX2014. The organization employs a small team dedicated to advancing these innovative treatments. Opus Genetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Opus Genetics stock

Total Assets per Share of Opus Genetics is 0.73 USD in 2025.

Total Assets per Share of Opus Genetics changed from 0.53 USD to 0.73 USD, representing a 36.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share Opus Genetics since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Opus Genetics

All Key Metrics — Opus Genetics